Evaluate the Efficacy and Safety of EN001 in Patients With Sarcopenia

Sex: All

Ages: 60 Years – N/A

Healthy volunteers: No

Phase: PHASE1, PHASE2

Enrollment: 132

Sponsor: ENCell

Summary

A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase 1/2 Clinical Trial to Evaluate the Efficacy and Safety of EN001 in Patients with Sarcopenia

Eligibility Criteria

Inclusion Criteria: * 1\) Male or Female aged 60 years or older at the time of providing written consent. : Female subjects must meet one of the following criteria for postmenopausal women\* : * Postmenopausal women: * Natural amenorrhea for 12 months * At least 6 weeks after surgical menopause (bilateral oophorectomy) * 2\) Individuals diagnosed with sarcopenia at the time of screening, based on the diagnostic criteria in Section 15.1 of the Asian Working Group for Sarcopenia(AWGS) 2019 guidlines, meeting (1) or (2) together with (3): * (1) Handgrip Strength: \< 28kg(men), \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07808905). StuddyBuddy aggregates publicly available trial information.